Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Effect of Supplemental Ascorbate on Defersirox Iron Chelation In the Iron-Loaded Gerbil

Maya Otto-Duessel, MS, Casey Brewer, BS, Aleya Hyderi, BS, Jens Lykkesfeldt, PhD, Ignacio Gonzalez-Gomez, MD, Hanspeter Nick, PhD, John C Wood, MD, PhD

Blood (2010) 116 (21): 2059.

https://doi.org/10.1182/blood.V116.21.2059.2059

Published: 2010

Journal Articles

Comparison of Two Animal Models for Evaluation of Defersirox Iron Chelation

Maya Otto-Duessel, MS, Casey Brewer, BS, Aleya Hyderi, BS, Jens Lykkesfeldt, PhD, Peter Nielson, PhD, Hanspeter Nick, PhD, John C Wood, MD, PhD

Blood (2010) 116 (21): 4244.

https://doi.org/10.1182/blood.V116.21.4244.4244

Published: 2010

Journal Articles

Influence of Iron Chelation Therapy on R1 and R2 Calibration Curves in Gerbil Liver and Heart.

John C. Wood, MD, PhD, Michelle I. Aguilar, BS, Maya Otto-Duessel, MS, Hanspeter Nick, PhD, Marvin D. Nelson, MD, Rex Moats, PhD

Blood (2006) 108 (11): 1775.

https://doi.org/10.1182/blood.V108.11.1775.1775

Published: 2006

Journal Articles

Twice-Daily Deferasirox Improves Cardiac Iron Chelation in the Gerbil Model of Iron Cardiomyopathy.

Maya Otto-Duessel, MS, Michelle I. Aguilar, BS, Hanspeter Nick, PhD, Rex Moats, PhD, John C. Wood, MD, PhD

Blood (2006) 108 (11): 1777.

https://doi.org/10.1182/blood.V108.11.1777.1777

Published: 2006

Journal Articles

ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.

John C. Wood, MD, PhD, Maya Otto-Duessel, MS, Ignacio Gonzales, MD, Michelle Aguilar, BS, Hanspeter Nick, PhD, Hiro Shimada, MD, Rex Moats, PhD

Blood (2005) 106 (11): 2695.

https://doi.org/10.1182/blood.V106.11.2695.2695

Published: 2005

Journal Articles

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Ellen B. Fung, PhD, RD, Filomena Longo, MD, Roland Fischer, PhD, Rainer Engelhardt, PhD, Zahra Pakbaz, MD, Herbert Optiz, PhD, Robert L. Fagaly, PhD, Hanspeter Nick, PhD, Peter Nielsen, MD, PhD, Elliott Vichinsky, MD, Antonio Piga, MD, Paul Harmatz, MD

Blood (2005) 106 (11): 3721.

https://doi.org/10.1182/blood.V106.11.3721.3721

Published: 2005

Journal Articles

Dose Response of Deferoxamine, Deferiprone, and ICL670 Chelation Therapy in a Gerbil Model of Iron Overload.

John C. Wood, MD, PhD, Maya Otto-Duessel, MS, Michelle Aguilar, BS, Hanspeter Nick, PhD, Thomas D. Coates, MD, Moats Rex, PhD

Blood (2004) 104 (11): 3621.

https://doi.org/10.1182/blood.V104.11.3621.3621

Published: 2004

Journal Articles

Cardiac MRI (T2,T2*) Predicts Cardiac Iron in the Gerbil Model of Iron Cardiomyopathy.

John C. Wood, MD, PhD, Maya Otto-Duessel, MS, Michelle Aguilar, BS, Hanspeter Nick, PhD, Marvin D. Nelson, MD, Thomas D. Coates, MD, Rex Moats, PhD

Blood (2004) 104 (11): 376.

https://doi.org/10.1182/blood.V104.11.376.376

Published: 2004

NARROW

The Effect of Supplemental Ascorbate on Defersirox Iron Chelation In the Iron-Loaded Gerbil

Comparison of Two Animal Models for Evaluation of Defersirox Iron Chelation

Influence of Iron Chelation Therapy on R1 and R2 Calibration Curves in Gerbil Liver and Heart.

Twice-Daily Deferasirox Improves Cardiac Iron Chelation in the Gerbil Model of Iron Cardiomyopathy.

ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.

Comparison of Liver Iron Concentration Measured by the SQUID Biosusceptometers at Hamburg, Torino and Oakland in Patients with Thalassemia and Sickle Cell Disease.

Dose Response of Deferoxamine, Deferiprone, and ICL670 Chelation Therapy in a Gerbil Model of Iron Overload.

Cardiac MRI (T2,T2*) Predicts Cardiac Iron in the Gerbil Model of Iron Cardiomyopathy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only